Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
Woman and Man Max 99 years
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
Update Il y a 4 ans
A four-arm randomised, double-blind, placebo-controlled, multicentre Phase II study to evaluate the safety, tolerability and efficacy as assessed by frequent MRI measures of three doses of atacicept monotherapy in subjects with relapsing multiple sclerosis (RMS) over a 36 weeks treatment course
The primary objective of the study is to evaluate the efficacy of three doses of atacicept to reduce CNS inflammation in subjects with RMS as assessed by frequent MRI.
Country
None
organs
None
Specialty
None
Closed trial
More information